|
|
|
Volumn 9, Issue 3, 1998, Pages 126-135
|
|
Rejection of the liver transplant
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
BLOOD GROUP ANTIBODY;
CALCINEURIN;
CD3 ANTIGEN;
CD86 ANTIGEN;
CORTICOSTEROID;
CYCLOSPORIN;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
GLYCOPROTEIN GP 39;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
LEFLUNOMIDE;
MAJOR HISTOCOMPATIBILITY ANTIGEN;
METHYLPREDNISOLONE;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
RAPAMYCIN;
TACROLIMUS;
ARTICLE;
BLOOD CLOTTING DISORDER;
BLOOD GROUP ABO SYSTEM;
CYTOKINE RELEASE;
DIABETES MELLITUS;
DIAGNOSIS;
DIARRHEA;
DRUG WITHDRAWAL;
GRAFT REJECTION;
GRAFT VERSUS HOST REACTION;
HISTOCOMPATIBILITY TEST;
HLA SYSTEM;
HOST RESISTANCE;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
IMMUNOREACTIVITY;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOCYTE COUNT;
LIVER TRANSPLANTATION;
NAUSEA;
NEPHROTOXICITY;
ABO BLOOD-GROUP SYSTEM;
BLOOD GROUPING AND CROSSMATCHING;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HLA ANTIGENS;
HUMANS;
INCIDENCE;
LIVER;
LIVER TRANSPLANTATION;
MALE;
PROGNOSIS;
RISK FACTORS;
|
|
EID: 0031692151
PISSN: 10495118
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (14)
|
|
References (65)
|
